Simone, oncology polymath and leader

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Joe Simone was oncology’s polymath. Skilled and adept in patient care, scientific and clinical discovery, administrative leadership, education as well as mentoring to a generation of oncologists through his writings.

00003893-005
Simone with a patient at St. Jude Children’s Research Hospital in 1970. Photo courtesy of St. Jude Children’s Research Hospital.

Over the years we worked together on many shared endeavors including the National Comprehensive Cancer Network, the Huntsman Cancer Institute, and many cancer policymaking organizations. He was forever creative, insightful and astute.

But Joe’s genuine affection and respect for his colleagues and friends spilled over into everything he did.

Joe and I ran for president of ASCO in the same year. With the organization heavily weighted toward medical oncologists rather than pediatricians, that more than anything else enabled me to win.

Shortly after the election I received a handwritten letter from Joe. It said, in essence, that although he had hoped he would win, he was very pleased to see me in that role and hoped that we would have many opportunities to work together in the future.

Thirty years later, I still have that letter. Joe made a lasting impact on oncology and as well as on so many of his colleagues.

He will remain forever in the lives of so many of us.


The author is the former president, chief executive officer, and chancellor,

Fox Chase Cancer Center


Joseph V. Simone’s book, “Simone’s Maxims,” is available for download through the Cancer History Project.

Robert C. Young, MD
Former president, chief executive officer, and chancellor, Fox Chase Cancer Center
Table of Contents

YOU MAY BE INTERESTED IN

The University of California, San Francisco and global oncology communities mourn the death of Felix Y. Feng, MD, a radiation oncologist and a leading figure in genitourinary cancer research. A professor of radiation oncology, urology and medicine, and vice chair of translational research at the UCSF Helen Diller Family Comprehensive Cancer Center, Feng died from cancer on Dec.10, 2024. He was 48.
The late Felix Feng, MD (center) with researchers Jonathan Chou, MD, PhD (left) and Lisa Chesner, PhD (right), in 2019.Photo by Noah BergerFelix Y. Feng, a genitourinary cancer research leader, died on Dec. 10, 2024. He was 48.This article is republished with permission by NRG Oncology.Dr. Feng was the former NRG Oncology Genitourinary Cancer Committee chair and an RTOG Foundation member. After years of dedicated and enthusiastic commitment to the NRG and previously the RTOG Genitourinary Cancer Committee, chairing or co-chairing 13 research protocols for NRG and RTOG, Dr. Feng was appointed committee chair in March 2018, following in the footsteps of Dr. Howard Sandler, his mentor. Dr. Feng was also a member of the RTOG Foundation Board of Directors.
Robert C. Young, MD
Former president, chief executive officer, and chancellor, Fox Chase Cancer Center

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login